Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma is an aggressive non-Hodgkin's lymphoma without a standard therapy for patients who relapse after or are not eligible for salvage autologous stem cell transplantation. In vitro analysis of lymphoma cell lines has shown that everolimus can inhibit cell cycle progres...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barnes, Jeffrey A., Jacobsen, Eric, Feng, Yang, Freedman, Arnold, Hochberg, Ephraim P., LaCasce, Ann S., Armand, Philippe, Joyce, Robin, Sohani, Aliyah R., Rodig, Scott J., Neuberg, Donna, Fisher, David C., Abramson, Jeremy S.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2013
Assuntos:
Original Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659994/
https://ncbi.nlm.nih.gov/pubmed/23144193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.075184
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados